獣医抗感染症薬の世界市場レポート2025年

獣医抗感染症薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で86億9,000万米ドルに成長します。予測期間の成長は、ペット数の継続的な増加、新興の人獣共通感染症、ペット取引の世界化、獣医ヘルスケア支出の増加に起因しています。予測期間の主な動向には、技術の進歩、生物学的製剤の採用増加、動物医療サービスにおけるテレヘルスの統合、天然素材やハーブの代替品への注目、動物用医薬品におけるeコマースの拡大、提携やパートナーシップなどがあります。

今後5年間の成長率9.6％という予測は、前回の予測から0.1％の微減を反映しています。この減少は主に米国と他国との間の関税の影響によるものです。滅菌インプットと発酵ベースの活性剤に対する関税は、生産能力を低下させ、新しい抗感染症製剤の上市を遅らせる可能性があります。また、相互関税や、貿易の緊張と制限の高まりによる世界経済と貿易への悪影響により、その影響はより広範囲に及ぶと思われます。

ペット飼育の増加が今後の獣医抗感染症薬市場の成長を牽引すると予想されます。ペット飼育とは、家庭で犬や猫などの家畜を飼うことを指します。ペットを家族の一員と考え、飼う若い人が増えており、多くの飼い主はペットの交友関係、忠誠心、孤独感を和らげる能力に動機づけられています。例えば、2022年、オーストラリアに本部を置く非政府組織Animal Medicines Australiaのデータによると、ペットの所有者数は28,730.8人に達し、2021年の39％から大幅に増加しています。これはペットの飼育とペットケアへの投資の強い増加傾向を反映しており、24％の増加を示しています。ペット飼育数の増加は、オーストラリアの家庭におけるペットの魅力の高まりを浮き彫りにしています。このように、ペット飼育の増加は獣医抗感染症薬市場の需要を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の獣医抗感染症薬：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の獣医抗感染症薬市場：成長率分析
• 世界の獣医抗感染症薬市場の実績：規模と成長, 2019-2024
• 世界の獣医抗感染症薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界の獣医抗感染症薬：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の獣医抗感染症薬市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗菌剤
• 抗ウイルス剤
• 抗真菌剤
• その他の薬物クラス
• 世界の獣医抗感染症薬市場：種属別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 家畜
• コンパニオンアニマル
• 世界の獣医抗感染症薬市場：投与方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 非経口
• 外用
• 世界の獣医抗感染症薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 獣医クリニック
• 薬局
• その他の流通チャネル
• 世界の獣医抗感染症薬市場、抗菌剤の薬剤クラス別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• 消毒剤
• 世界の獣医抗感染症薬市場、抗ウイルス剤の薬剤クラス別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ワクチン
• 抗ウイルス薬
• 世界の獣医抗感染症薬市場、抗真菌剤の薬剤クラス別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所抗真菌薬
• 全身性抗真菌薬
• 世界の獣医抗感染症薬市場、その他の薬剤の薬剤クラス別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 寄生虫駆除剤
• 免疫調節薬
• 消毒剤

第7章 地域別・国別分析

• 世界の獣医抗感染症薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の獣医抗感染症薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医抗感染症薬市場：競合情勢
• 獣医抗感染症薬市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • C. H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Vetoquinol S. A.
• Merck & Co.
• Phibro Animal Health
• Aspen Veterinary Resources Ltd.
• Bimeda Animal Health Limited
• Dechra Pharmaceuticals Plc
• Intervet International B. V.
• Oceanic Pharmachem Pvt. Ltd.
• Virbac Ltd.
• Indian Immunologicals Ltd.（IIL）
• Norbrook Laboratories Ltd.
• Ashish Life Science Pvt. Ltd.
• Kyoritsu Seiyaku Corporation
• Tianjin Ringpu Bio-Technology Co. Ltd.
• HIPRA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 獣医抗感染症薬市場2029：新たな機会を提供する国
• 獣医抗感染症薬市場2029：新たな機会を提供するセグメント
• 獣医抗感染症薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The term veterinary anti-infective encompasses a wide range of methods aimed at preventing and treating illnesses in animals. These products are utilized in veterinary medicine to promote the health and well-being of both livestock and pets, as well as to control disease outbreaks within animal populations.

The main types of drug classes in veterinary anti-infectives include antimicrobial agents, antiviral agents, antifungal agents, and others. Antimicrobial agents are substances, either natural or synthetic, that function by killing or inhibiting the growth of microorganisms such as bacteria, fungi, and algae. Various species, including livestock animals and companion animals, are involved in the administration of these drugs through oral, parenteral, and topical modes. Distribution channels for veterinary anti-infectives include veterinary hospitals, veterinary clinics, pharmacies, and other relevant outlets.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary anti-infectives market research report is one of a series of new reports from The Business Research Company that provides veterinary anti-infectives market statistics, including veterinary anti-infectives industry global market size, regional shares, competitors with veterinary anti-infectives market share, detailed veterinary anti-infectives market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary anti-infectives industry. This veterinary anti-infectives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary anti-infectives market size has grown strongly in recent years. It will grow from $5.54 billion in 2024 to $6.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing pet ownership, prevalence of infectious diseases, advancements in veterinary medicine, rising awareness, government initiatives.

The veterinary anti-infectives market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to continued pet population growth, emerging zoonotic diseases, globalization of pet trade, increasing veterinary healthcare expenditure. Major trends in the forecast period include technological advancements, increasing adoption of biologicals, integration of telehealth in veterinary services, focus on natural and herbal alternatives, expansion of e-commerce in veterinary pharmaceuticals, collaborations and partnerships.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on sterilization inputs and fermentation-based actives could reduce production capacity and delay the launch of new anti-infective formulations. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

An increase in pet ownership is anticipated to drive the growth of the veterinary anti-infectives market in the future. Pet ownership refers to having dogs, cats, or other domestic animals at home. More young individuals are adopting pets, viewing them as family members, and many owners are motivated by the pets' companionship, loyalty, and ability to alleviate loneliness. For instance, in 2022, data from Animal Medicines Australia, a non-governmental organization based in Australia, indicated a significant rise in pet ownership, with the number of pet owners reaching 28,730.8, compared to 39% in 2021. This marks a 24% increase, reflecting a strong upward trend in pet adoption and investment in pet care. The rise in pet ownership highlights the growing appeal of pets within Australian households. Thus, the increase in pet ownership is fueling demand for the veterinary anti-infectives market.

The veterinary anti-infectives market is expected to witness growth due to the increasing trend of rising livestock production. Livestock, including cattle, sheep, pigs, chickens, and goats, are raised for various purposes, such as food production, labor, and companionship. Veterinary anti-infectives play a crucial role in treating infections in animals, ensuring their health and well-being, and preventing and controlling diseases. According to the National Agricultural Statistics Service, in the US, there were approximately 28. 9 million beef cows, 9. 4 million dairy cows, and an estimated 11. 1 million cattle on feed in 2022. The expanding livestock production contributes to the growth of the veterinary anti-infectives market.

Major players in the veterinary anti-infectives market are forming strategic partnerships to address the threat of antimicrobial resistance (AMR). Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in November 2022, the Food and Agriculture Organization of the United Nations (FAO), the UN Environment Programme (UNEP), the World Health Organization (WHO), and the World Organization for Animal Health (WOAH), collectively known as the Quadripartite, launched the Antimicrobial Resistance Multi-Stakeholder Partnership Platform. This initiative aims to highlight the risks that AMR poses to humans, animals, plants, ecosystems, and livelihoods, as well as to ensure that the increasing challenges and consequences of antimicrobial resistance are addressed on a global scale.

Strategic partnerships are another significant approach adopted by major players in the veterinary anti-infectives market to address the threat of antimicrobial resistance. In November 2022, The Food and Agriculture Organization of the United Nations (FAO), the UN Environment Programme (UNEP), the World Health Organization (WHO), and the World Organization for Animal Health (WOAH) jointly launched The Antimicrobial Resistance Multi-Stakeholder Partnership Platform. This initiative aims to highlight the global threat posed by antimicrobial resistance and ensure a coordinated international effort to address its challenges and consequences.

In June 2022, Ceva Sante Animale, a multinational animal health company based in France, acquired Artemis Technologies, Inc., a Canada-based oral rabies vaccine manufacturer, for an undisclosed amount. This strategic acquisition enhances Ceva's rabies portfolio and expands its market footprint in North America.

Major companies operating in the veterinary anti-infectives market include Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

North America was the largest region in the veterinary anti-infectives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary anti-infectives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The veterinary anti-infectives market consists of revenues earned by entities by providing antibacterial that are used to prevent and treat animal diseases such as infections. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Anti-infectives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary anti-infectives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary anti-infectives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary anti-infectives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Antimicrobial Agents; Antiviral Agents; Antifungal Agents; Other Drug Classes
• 2) By Species Type: Livestock Animals; Companion Animals
• 3) By Mode Of Administration: Oral; Parenteral; Topical
• 4) By Distribution Channel: Veterinary Hospitals; Veterinary Clinics; Pharmacies; Others Distribution Channels
• Subsegments:
• 1) By Antimicrobial Agents: Antibiotics; Antiseptics
• 2) By Antiviral Agents: Vaccines; Antiviral Medications
• 3) By Antifungal Agents: Topical Antifungals; Systemic Antifungals
• 4) By Other Drug Classes: Parasiticides; Immune Modulators; Disinfectants
• Companies Mentioned: Bayer AG; C. H. Boehringer Sohn AG & Co. KG; Ceva Sante Animale; Elanco Animal Health Incorporated; Zoetis Inc.; Vetoquinol S. A.; Merck & Co.; Phibro Animal Health; Aspen Veterinary Resources Ltd.; Bimeda Animal Health Limited; Dechra Pharmaceuticals Plc; Intervet International B. V.; Oceanic Pharmachem Pvt. Ltd.; Virbac Ltd.; Indian Immunologicals Ltd. (IIL); Norbrook Laboratories Ltd.; Ashish Life Science Pvt. Ltd.; Kyoritsu Seiyaku Corporation; Tianjin Ringpu Bio-Technology Co. Ltd.; HIPRA; Zydus Animal Health and Investments Limited; China Animal Husbandry Group; ZOOVETVARU Ltd.; Magnum Veterinaaria Ltd.; Inovet (V. M. D. nv/sa); Chanelle Pharmaceuticals Manufacturing Ltd.; Huvepharma Inc.; Veyx Pharma GmbH; Biovet Pvt. Ltd.; Laboratorios Ovejero SA; Laboratorios Syva S. A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Anti-infectives Market Characteristics

3. Veterinary Anti-infectives Market Trends And Strategies

4. Veterinary Anti-infectives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Veterinary Anti-infectives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Anti-infectives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Anti-infectives Market Growth Rate Analysis
• 5.4. Global Veterinary Anti-infectives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Anti-infectives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Anti-infectives Total Addressable Market (TAM)

6. Veterinary Anti-infectives Market Segmentation

• 6.1. Global Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antimicrobial Agents
• Antiviral Agents
• Antifungal Agents
• Other Drug Classes
• 6.2. Global Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Livestock Animals
• Companion Animals
• 6.3. Global Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Topical
• 6.4. Global Veterinary Anti-infectives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies
• Other Distribution Channels
• 6.5. Global Veterinary Anti-infectives Market, Sub-Segmentation Of Antimicrobial Agents, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Antiseptics
• 6.6. Global Veterinary Anti-infectives Market, Sub-Segmentation Of Antiviral Agents, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vaccines
• Antiviral Medications
• 6.7. Global Veterinary Anti-infectives Market, Sub-Segmentation Of Antifungal Agents, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Antifungals
• Systemic Antifungals
• 6.8. Global Veterinary Anti-infectives Market, Sub-Segmentation Of Other Drug Classes, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parasiticides
• Immune Modulators
• Disinfectants

7. Veterinary Anti-infectives Market Regional And Country Analysis

• 7.1. Global Veterinary Anti-infectives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Anti-infectives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Anti-infectives Market

• 8.1. Asia-Pacific Veterinary Anti-infectives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Anti-infectives Market

• 9.1. China Veterinary Anti-infectives Market Overview
• 9.2. China Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Anti-infectives Market

• 10.1. India Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Anti-infectives Market

• 11.1. Japan Veterinary Anti-infectives Market Overview
• 11.2. Japan Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Anti-infectives Market

• 12.1. Australia Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Anti-infectives Market

• 13.1. Indonesia Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Anti-infectives Market

• 14.1. South Korea Veterinary Anti-infectives Market Overview
• 14.2. South Korea Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Anti-infectives Market

• 15.1. Western Europe Veterinary Anti-infectives Market Overview
• 15.2. Western Europe Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Anti-infectives Market

• 16.1. UK Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Anti-infectives Market

• 17.1. Germany Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Anti-infectives Market

• 18.1. France Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Anti-infectives Market

• 19.1. Italy Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Anti-infectives Market

• 20.1. Spain Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Anti-infectives Market

• 21.1. Eastern Europe Veterinary Anti-infectives Market Overview
• 21.2. Eastern Europe Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Anti-infectives Market

• 22.1. Russia Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Anti-infectives Market

• 23.1. North America Veterinary Anti-infectives Market Overview
• 23.2. North America Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Anti-infectives Market

• 24.1. USA Veterinary Anti-infectives Market Overview
• 24.2. USA Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Anti-infectives Market

• 25.1. Canada Veterinary Anti-infectives Market Overview
• 25.2. Canada Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Anti-infectives Market

• 26.1. South America Veterinary Anti-infectives Market Overview
• 26.2. South America Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Anti-infectives Market

• 27.1. Brazil Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Anti-infectives Market

• 28.1. Middle East Veterinary Anti-infectives Market Overview
• 28.2. Middle East Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Anti-infectives Market

• 29.1. Africa Veterinary Anti-infectives Market Overview
• 29.2. Africa Veterinary Anti-infectives Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Anti-infectives Market, Segmentation By Species Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Anti-infectives Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Anti-infectives Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Anti-infectives Market Competitive Landscape
• 30.2. Veterinary Anti-infectives Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. C. H. Boehringer Sohn AG & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Anti-infectives Market Other Major And Innovative Companies

• 31.1. Vetoquinol S. A.
• 31.2. Merck & Co.
• 31.3. Phibro Animal Health
• 31.4. Aspen Veterinary Resources Ltd.
• 31.5. Bimeda Animal Health Limited
• 31.6. Dechra Pharmaceuticals Plc
• 31.7. Intervet International B. V.
• 31.8. Oceanic Pharmachem Pvt. Ltd.
• 31.9. Virbac Ltd.
• 31.10. Indian Immunologicals Ltd. (IIL)
• 31.11. Norbrook Laboratories Ltd.
• 31.12. Ashish Life Science Pvt. Ltd.
• 31.13. Kyoritsu Seiyaku Corporation
• 31.14. Tianjin Ringpu Bio-Technology Co. Ltd.
• 31.15. HIPRA

32. Global Veterinary Anti-infectives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Anti-infectives Market

34. Recent Developments In The Veterinary Anti-infectives Market

35. Veterinary Anti-infectives Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Anti-infectives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Anti-infectives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Anti-infectives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer